Ajooni Biotech
- Market cap
- ₹ 53 Cr.
- P/E
- 13.5x
- P/B
- 0.56x
- 52-week range
- 2.68 – 5.5
- ROE
- 5%
- ROCE
- 6%
- Dividend yield
- 0%
- Debt / equity
- 0.19
- Sector
- Food Products
- Industry
- Animal Feed
- Listed on
- NSE
About
Ajooni Biotech Limited is an animal health care solutions company. The Company is specialized in compounded animal feed and feed supplements. Its portfolio offers a wide range of quality cattle feed; cattle feed chips, camel feed, cotton oil cake, mustard oil cake and a wide range of feed supplements to cover the entire life cycle of an animal. The Company uses technologies for all its operations, such as Enterprise Resource Planning (ERP) software, programmable logic controller (PLC) system to control production process. It offers products for oral calclum, bloating, calclum gel, mastitis powder, mineral mixture, batisa powder, liver tonic, reproduction powder, utrine tonic, milk gainer, multi vitamin, growth promoter, foot and mouth disease (FMD) powder, cough syrup, egg growth promoter, and heat stock powder. Its feed supplements include CALTUS, 4U, LIVTUS, RUMITUS, Mustmin, AUTOVITA and others. Its cattle feed products include Gold Magic plus, Silver Magic, 3 Star, among others.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Animal Feed: 9 companies →Ajooni Biotech against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)13.5 against a typical 19.5: cheaper than most peers (1st = cheapest).3rd of 8
- Sales growth+103% against a typical +56.3% from a year earlier.2nd of 8
- Profit growth−44.9% against a typical −20.3% from a year earlier.7th of 8
- Share price, 3 months−25.3% against a typical +3.3%.5th of 7
- Size₹ 52.6 Cr. market value against a typical ₹ 259.9 Cr. (1st = largest).6th of 7
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Look closer
Rated BB+ by CRISIL- No warnings from the agency.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CRISIL | Crisil BB+ | Stable | 4 May 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 4 May 2026 | Reaffirmed | Crisil BB+(Issuer Not Cooperating) → Crisil BB+ | — | CRISIL | ₹ 15 Cr. | |
| 30 Jan 2026 | Reaffirmed | Crisil BB+(Issuer Not Cooperating) | — | CRISIL | ₹ 15 Cr. | |
| 8 Aug 2025 | Rating action | Crisil BB+(Issuer Not Cooperating) | — | CRISIL | ₹ 15 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 14 Aug 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 29 Jun 2026 | Fund Raising/Other business matters | To consider Fund Raising and other business matters |
| 28 May 2026 | Financial Results | To consider and approve the financial results for the period ended March 31, 2026 |
| 30 Jan 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2025 and other business matters |
| 13 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 29 Aug 2025 | Other business matters | To consider other business matters |
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 19 | 20 | 20 | 26 | 26 | 34 | 29 | 31 | 32 | 59 | 61 | 63 |
| Expenses | 19 | 21 | 18 | 25 | 25 | 33 | 28 | 31 | 30 | 56 | 60 | 62 |
| Operating Profit | 1 | −1 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 2 |
| OPM % | 3.2% | −3.2% | 8.1% | 3.7% | 3% | 2.7% | 3.5% | 2.3% | 4.7% | 5.2% | 1.7% | 2.6% |
| Other Income | 0 | 2 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Profit before tax | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 1 |
| Tax % | 23.1% | 23.7% | 38.7% | 25.4% | 22.8% | 27.7% | 19.4% | 24.3% | 24.4% | 30.1% | 15.2% | 34.9% |
| Net Profit | 0 | 0 | 1 | 0 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 0 |
| EPS in Rs | 0.02 | 0.03 | 0.05 | 0.03 | 0.04 | 0.04 | 0.09 | 0.05 | 0.05 | 0.1 | 0.06 | 0.02 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 30%
- 5 Years
- 29%
- 3 Years
- 35%
- TTM
- 78%
- 10 Years
- 46%
- 5 Years
- 63%
- 3 Years
- 57%
- TTM
- 8%
- 10 Years
- —
- 5 Years
- −22%
- 3 Years
- 3%
- TTM
- —
- 10 Years
- 5%
- 5 Years
- 5%
- 3 Years
- 5%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Ajooni Biotech | ₹ 2.96 | ₹ 53 Cr. | 13.5x | 0.6x | 5% | — |
| Nestle India | ₹ 1,173.45 | ₹ 2,26,278 Cr. | 80.4x | 53.4x | 76.3% | 15.1% |
| Britannia Industries | ₹ 4,547.80 | ₹ 1,09,542 Cr. | 51.5x | 25.5x | 53.6% | 13.3% |
| Tata Consumer Products | ₹ 960.00 | ₹ 95,010 Cr. | 67.4x | 4.9x | 7.4% | 8.1% |
| Godrej Industries | ₹ 918.00 | ₹ 30,884 Cr. | 34.9x | 4x | 11.6% | 10.9% |
| Patanjali Foods | ₹ 351.00 | ₹ 38,193 Cr. | 18.9x | 2.8x | 14.8% | 4.5% |
Management
- Charanjit Singh
- Chief Financial Officer
- Sandeep Goyal
- Compliance Officer, Company Secretary
- Jasjot Singh
- Managing Director, Executive Director
- Partek Singh
- Executive and Non Independent Director
Prices are delayed and for information only. Nothing on this page is investment advice.